Navigation Links
Vitamin D may lower blood pressure in African-Americans
Date:3/13/2013

Boston High blood pressure, a risk factor for heart attacks, heart failure and stroke, is 40 percent more common in African-Americans than in other American ethnic groups. In a new study from Brigham and Women's Hospital (BWH), along with the Dana-Farber Cancer Institute and Massachusetts General Hospital, researchers show that vitamin D supplementation may help African-Americans lower their blood pressure. The study publishes online in the March 13, 2013 edition of the American Heart Association journal Hypertension.

"This study may explain and help treat an important public health disparity," said the study's lead author, John Forman, MD, a physician in the Renal Division and Kidney Clinical Research Institute at BWH. "More research is needed, but these data may indicate that vitamin D supplementation lowers blood pressure in African-Americans."

To conduct the study, 250 African-American adult voluntary research participants were divided into four groups. Three of the groups received a three-month regimen of daily vitamin D supplementation at various doses that ranged between 1,000 and 4,000 units. The fourth group received a placebo. Participants in the placebo group saw their systolic blood pressure rise, but participants in the supplementation group had their systolic blood pressure decrease by one to four points, with those who received the highest dose benefiting the most. Systolic blood pressure is the top number in a blood pressure reading; it measures the pressure in the arteries when the heart beats.

"The gains were modest, but significant," said Forman. "If further research supports our finding, widespread use of vitamin D supplementation in African-Americans could have significant public health benefits."


'/>"/>

Contact: Tom Langford
tlangford@partners.org
617-534-1605
Brigham and Women's Hospital
Source:Eurekalert

Page: 1

Related medicine news :

1. Vitamin E in diet protects against many cancers
2. Researchers determine vitamin D blood level for reducing major medical risks in older adults
3. Vitamin K2: New hope for Parkinsons patients?
4. Experts call for clinical trials to test non-skeletal benefits of vitamin D
5. Vitamin D + TB vaccine: Allies in fight against bladder cancer?
6. Vitamin C improves pulmonary function in newborns of pregnant smoking women
7. Vitamin C improves lung function in newborns of pregnant smoking women
8. Japanese-American Men With Low Vitamin-D Diet Face Higher Stroke Risk
9. Too much vitamin D can be as unhealthy as too little
10. Older adults may need more vitamin D to prevent mobility difficulties
11. Older Women Should Not Take Calcium, Vitamin D: Task Force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 2017 , ... RawTrition now brings you BioEnergy which is a powder capsule ... , RawTrition is taking nutrients to the next level! The superfoods in ... raw form (unlike the synthetically made options that are on the market). , Founder ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... cream that’s the first in a new class of photodynamic cosmetics (PDC). , ... of skin, visibly reduce outward signs of aging, and minimize the appearance of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... CEOs, CFOs and HR decision-makers are preparing for how his administration could impact ... will provide insight into what changes are most likely to make it through ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... targets, they rely on contracted partners to help with process innovation in drug ... combined drug formulation experience along with state-of-the-art analytical equipment in support of their ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... of predictive analytics to its patient care management module. Using this new feature, ... a patient has been initiated on continuous positive airway pressure (CPAP), oral, or ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology: